| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/19/2004 | CN1150175C Derivatives of 1,3,4-oxadiazolone |
| 05/19/2004 | CN1150172C 1,5 benzodiazepine derviatives |
| 05/19/2004 | CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders |
| 05/19/2004 | CN1150035C Recombination plasmid and application in disease prevention and control |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150028C Tri-, tetra-, penta- and polypeptides and their therapeuitc use as antidepressant agent |
| 05/19/2004 | CN1150006C Beetoxin injection and its preparing process |
| 05/19/2004 | CN1149996C Hexahydro-pyrido(4,3-B) indole derivatives as antipsychotic drugs |
| 05/19/2004 | CN1149991C Treatment of persistent pain |
| 05/19/2004 | CN1149989C Application of skullcat stem and leaf general flavone and wild baicalin in preparing dementia resisting medicine |
| 05/19/2004 | CN1149987C Pharmaceutical composition comprising combination of dextro-and laevo-isomers of sotalol |
| 05/19/2004 | CN1149986C Use of medicine made by paracetamol for treating photophoby related to migraine |
| 05/19/2004 | CN1149985C Pharmaceutical compositions comprising S-(-)-N-Propargyl-1-amino indan |
| 05/18/2004 | US6737518 Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737431 Benzoxazole derivatives as novel melatonergic agents |
| 05/18/2004 | US6737426 Such as (4-phenylsulfonyl-2-pyridin-3-yl-oxazol-5-yl)-methylamine; anticonvulsants, antiinflammatories, neuro-protectants, cerebroprotectants, nootropics |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/18/2004 | US6737424 Alpha-substituted pyridazino quinoline compounds |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737087 Composition containing Asiasari Radix extracts for protecting brain cells and improving memory |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737043 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | CA2297279C New cyano-indole compounds that inhibit serotonin recapture, the process for their preparation and the pharmaceutical compounds that contain them |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 05/18/2004 | CA2225746C 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 05/13/2004 | WO2004039979A1 Means and methods for diagnosing and treating idiopathic generalized epilepsy (ige) |
| 05/13/2004 | WO2004039972A1 H17t213-transgenic animal, novel h17t213 protein and dna thereof |
| 05/13/2004 | WO2004039835A2 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone |
| 05/13/2004 | WO2004039802A1 Substituted pyrido-pyridazine derivatives which enhance cognition via the gaba-a receptor |
| 05/13/2004 | WO2004039800A1 Cyclic sulfamides for inhibition of gamma-secretase |
| 05/13/2004 | WO2004039797A1 A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039778A1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/13/2004 | WO2004039753A2 Phenyl compounds |
| 05/13/2004 | WO2004039404A1 Therapeutic agent for spinal canal stenosis |
| 05/13/2004 | WO2004039403A1 Remedy for corneal failure |
| 05/13/2004 | WO2004039396A1 Drug containing angiotensin convertase |
| 05/13/2004 | WO2004039385A2 Mucuna pruriens and extracts thereof for the treatment of neurological diseases |
| 05/13/2004 | WO2004039383A1 Remedy for fibromyalgia |
| 05/13/2004 | WO2004039377A1 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 05/13/2004 | WO2004039372A1 Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine |
| 05/13/2004 | WO2004039371A2 Compositions of cyclooxygenase-2 selective inhibitors and nmda receptor antagonists for the treatment or prevention of neuropathic pain |
| 05/13/2004 | WO2004039370A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
| 05/13/2004 | WO2004039367A1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 05/13/2004 | WO2004039313A2 Preventing desensitization of receptors |
| 05/13/2004 | WO2004024709A3 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
| 05/13/2004 | WO2004019960A3 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 05/13/2004 | WO2004017950A3 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 05/13/2004 | WO2004013101A3 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 05/13/2004 | WO2004005294A3 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
| 05/13/2004 | WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003080022A3 Analgesics for nasal administration |
| 05/13/2004 | WO2003079986A3 Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003070280A3 Absorption enhancing agent |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003037337A8 Depot formulations of iloperidone and a star polymer |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2002064735A3 Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
| 05/13/2004 | WO2002055013A8 Therapeutic chromone compounds |
| 05/13/2004 | WO2002048102A3 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses |
| 05/13/2004 | WO2002034272A3 Methods of improving central nervous system functioning |
| 05/13/2004 | WO2002024146A9 Methods of decreasing or preventing pain using spicamycin derivatives |
| 05/13/2004 | US20040093625 Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092744 Process for preparing crystalline form I of cabergoline |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092605 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 05/13/2004 | US20040092601 Sustained released form |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092595 Analgesic agent |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092563 Angiotensin II antagonists |
| 05/13/2004 | US20040092562 Methods for treating inflammatory conditions or inhibiting JNK |
| 05/13/2004 | US20040092554 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092544 Synergistic mixture containing dopamine agent; muscular disorders; analgesics |
| 05/13/2004 | US20040092542 Tamper-resistant oral opioid agonist formulations |
| 05/13/2004 | US20040092541 Analgesic mixture; side effect reduction |
| 05/13/2004 | US20040092537 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy |
| 05/13/2004 | US20040092534 Orally administering a capsule shaped tablet core dosage form containing paliperidone, releases paliperidone an ascending release rate form a prolonged period of time |
| 05/13/2004 | US20040092533 Central nervous system disorders; anxiolytic agents; anticonvulsants; cognition activators; side effect reduction |
| 05/13/2004 | US20040092531 Active substance combination containing an opioid having a fentanyl-type structure and ketamine |
| 05/13/2004 | US20040092530 Administering mixture of alanine and serine |
| 05/13/2004 | US20040092528 Brain disorders; psychological disorders; Alzheimer's disease; Parkinson's disease; schizophrenia |
| 05/13/2004 | US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092525 Pirazino(aza)indole derivatives |
| 05/13/2004 | US20040092519 New treatment for hot flashes |